• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡上皮损伤、修复及纤维化的机制。

Mechanisms of alveolar epithelial injury, repair, and fibrosis.

作者信息

Chambers Rachel C, Mercer Paul F

机构信息

Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom.

出版信息

Ann Am Thorac Soc. 2015 Mar;12 Suppl 1(Suppl 1):S16-20. doi: 10.1513/AnnalsATS.201410-448MG.

DOI:10.1513/AnnalsATS.201410-448MG
PMID:25830828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4430974/
Abstract

The challenge facing many fibrotic lung diseases is that these conditions usually present late, often after several decades of repetitive alveolar epithelial injury, during which functional alveolar units are gradually obliterated and replaced with nonfunctional connective tissue. The resulting fibrosis is often progressive and, in the case of idiopathic pulmonary fibrosis (IPF), invariably leads to respiratory insufficiency and, ultimately, the premature death of affected individuals. Recent years have seen a greater appreciation of the relative importance of chronic inflammation as a driver of fibrotic responses. Current evidence suggests that IPF arises as a result of repetitive epithelial injury and a highly aberrant wound healing response in genetically susceptible and aged individuals. Nonspecific anti-inflammatory agents offer no clinical benefit, but the potential contribution of maladaptive immune responses in determining outcome is gaining increasing recognition. The importance of key differences in the tissue-regenerative potential in young versus aged individuals is also beginning to be more fully appreciated. Moreover, there is considerable overlap in the mechanisms underlying tissue repair and cancer, and patients with IPF are at heightened risk of developing lung cancer. Progressive fibrosis and cancer may therefore represent the extremes of a highly dysregulated tissue injury response. This brief review focuses on some of this evidence and on our current understanding of abnormal tissue repair responses after chronic epithelial injury in the specific context of IPF.

摘要

许多肺纤维化疾病面临的挑战在于,这些病症通常在疾病晚期才出现,往往是在经历数十年反复的肺泡上皮损伤之后,在此期间功能性肺泡单位逐渐被破坏,并被无功能的结缔组织所取代。由此产生的纤维化通常呈进行性发展,就特发性肺纤维化(IPF)而言,最终会导致呼吸功能不全,并最终导致受影响个体过早死亡。近年来,人们越来越认识到慢性炎症作为纤维化反应驱动因素的相对重要性。目前的证据表明,IPF是由基因易感性和老年个体中反复的上皮损伤以及高度异常的伤口愈合反应引起的。非特异性抗炎药并无临床益处,但适应不良的免疫反应在决定疾病转归方面的潜在作用正日益受到认可。年轻个体与老年个体在组织再生潜力方面的关键差异的重要性也开始得到更充分的认识。此外,组织修复和癌症的潜在机制存在相当大的重叠,IPF患者患肺癌的风险更高。因此,进行性纤维化和癌症可能代表了高度失调的组织损伤反应的两个极端情况。本简要综述重点关注其中一些证据,以及我们目前对IPF特定背景下慢性上皮损伤后异常组织修复反应的理解。

相似文献

1
Mechanisms of alveolar epithelial injury, repair, and fibrosis.肺泡上皮损伤、修复及纤维化的机制。
Ann Am Thorac Soc. 2015 Mar;12 Suppl 1(Suppl 1):S16-20. doi: 10.1513/AnnalsATS.201410-448MG.
2
Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis.揭示特发性肺纤维化的进行性病理生理学。
Eur Respir Rev. 2012 Jun 1;21(124):152-60. doi: 10.1183/09059180.00001012.
3
Tissue remodelling in pulmonary fibrosis.肺纤维化中的组织重塑
Cell Tissue Res. 2017 Mar;367(3):607-626. doi: 10.1007/s00441-016-2543-2. Epub 2016 Dec 16.
4
Idiopathic pulmonary fibrosis: a disorder of epithelial cell dysfunction.特发性肺纤维化:一种上皮细胞功能障碍的疾病。
Am J Med Sci. 2011 Jun;341(6):435-8. doi: 10.1097/MAJ.0b013e31821a9d8e.
5
Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.转录组谱分析揭示特发性肺纤维化中上皮细胞的疾病特异性特征。
Respir Res. 2020 Jun 30;21(1):165. doi: 10.1186/s12931-020-01414-z.
6
Club cells inhibit alveolar epithelial wound repair via TRAIL-dependent apoptosis.肺泡细胞通过 TRAIL 依赖性凋亡抑制肺泡上皮细胞的伤口修复。
Eur Respir J. 2013 Mar;41(3):683-94. doi: 10.1183/09031936.00213411. Epub 2012 Jul 12.
7
Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.特发性肺纤维化的分子靶点与治疗的最新进展:聚焦于转化生长因子β信号传导与肌成纤维细胞
Curr Med Chem. 2009;16(11):1400-17. doi: 10.2174/092986709787846497.
8
Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.颗粒头样蛋白 2(GRHL2)的分布揭示了人类特发性肺纤维化和肺纤维化小鼠模型之间新的病理生理学差异。
Am J Physiol Lung Cell Mol Physiol. 2014 Mar 1;306(5):L405-19. doi: 10.1152/ajplung.00143.2013. Epub 2013 Dec 27.
9
The pathogenesis of idiopathic pulmonary fibrosis.特发性肺纤维化的发病机制。
Ther Adv Respir Dis. 2010 Dec;4(6):367-88. doi: 10.1177/1753465810379801. Epub 2010 Oct 15.
10
Inflammation and immunity in IPF pathogenesis and treatment.特发性肺纤维化发病机制和治疗中的炎症与免疫。
Respir Med. 2019 Feb;147:79-91. doi: 10.1016/j.rmed.2018.12.015. Epub 2019 Jan 9.

引用本文的文献

1
Mangiferin Against Respiratory Diseases: Pharmacological Targets and Prospects.芒果苷与呼吸系统疾病:药理靶点与前景
Pharmacol Res Perspect. 2025 Aug;13(4):e70163. doi: 10.1002/prp2.70163.
2
Single cell transcriptomics in a treatment-segregated cohort exposes a STAT3-regulated therapeutic gap in idiopathic pulmonary fibrosis.在一个按治疗分组的队列中进行的单细胞转录组学研究揭示了特发性肺纤维化中由STAT3调节的治疗差距。
bioRxiv. 2025 Jun 21:2025.06.16.659944. doi: 10.1101/2025.06.16.659944.
3
ECM formation and degradation during fibrosis, repair, and regeneration.纤维化、修复和再生过程中的细胞外基质形成与降解。
NPJ Metab Health Dis. 2025 Jun 10;3(1):25. doi: 10.1038/s44324-025-00063-4.
4
Qimai Feiluoping Decoction Inhibits EndMT to Alleviate Pulmonary Fibrosis by Reducing PI3K/AKT/mTOR Pathway-Mediated the Restoration of Autophagy.芪麦肺络平汤通过降低PI3K/AKT/mTOR信号通路介导的自噬恢复抑制上皮-间质转化以减轻肺纤维化
J Inflamm Res. 2025 Jun 26;18:8447-8475. doi: 10.2147/JIR.S515286. eCollection 2025.
5
Epithelial Cell Dysfunction in Pulmonary Fibrosis: Mechanisms, Interactions, and Emerging Therapeutic Targets.肺纤维化中的上皮细胞功能障碍:机制、相互作用及新兴治疗靶点
Pharmaceuticals (Basel). 2025 May 28;18(6):812. doi: 10.3390/ph18060812.
6
Current advancements in the mechanisms and animal models of acute exacerbation of pulmonary fibrosis: a systematic review.肺纤维化急性加重机制与动物模型的当前进展:一项系统综述
Front Pharmacol. 2025 May 30;16:1501085. doi: 10.3389/fphar.2025.1501085. eCollection 2025.
7
Collagen VII Is Associated with Airway Remodeling, Honeycombing, and Fibroblast Foci in Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis.Ⅶ型胶原蛋白与寻常型间质性肺炎/特发性肺纤维化中的气道重塑、蜂窝状改变及成纤维细胞灶相关。
Am J Pathol. 2025 Aug;195(8):1467-1483. doi: 10.1016/j.ajpath.2025.03.013. Epub 2025 Apr 29.
8
Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages.抑制Rho鸟苷酸交换因子(Rho GEFs)可通过抑制肌成纤维细胞活化和重编程促纤维化巨噬细胞来减轻肺纤维化。
Cell Death Dis. 2025 Apr 11;16(1):278. doi: 10.1038/s41419-025-07573-5.
9
Efficacy of ginkgo biloba extract in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis of randomized controlled trials.银杏叶提取物治疗特发性肺纤维化的疗效:一项随机对照试验的系统评价和荟萃分析
Front Pharmacol. 2025 Mar 5;16:1524505. doi: 10.3389/fphar.2025.1524505. eCollection 2025.
10
The histone demethylase KDM6B links obstructive sleep apnea to idiopathic pulmonary fibrosis.组蛋白去甲基化酶KDM6B将阻塞性睡眠呼吸暂停与特发性肺纤维化联系起来。
FASEB J. 2025 Jan 15;39(1):e70306. doi: 10.1096/fj.202402813R.

本文引用的文献

1
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.尼达尼布治疗特发性肺纤维化的疗效和安全性。
N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18.
2
Genetic determinants of pulmonary fibrosis: evolving concepts.遗传因素导致肺纤维化:概念的演进。
Lancet Respir Med. 2014 May;2(5):416-28. doi: 10.1016/S2213-2600(14)70047-5. Epub 2014 Apr 2.
3
Epigenetics of idiopathic pulmonary fibrosis.特发性肺纤维化的表观遗传学
Transl Res. 2015 Jan;165(1):48-60. doi: 10.1016/j.trsl.2014.03.011. Epub 2014 Mar 31.
4
Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute.特发性肺纤维化的基质生物学:美国国立心肺血液研究所研讨会报告
Am J Pathol. 2014 Jun;184(6):1643-51. doi: 10.1016/j.ajpath.2014.02.003. Epub 2014 Apr 13.
5
Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.揭示神秘特发性肺纤维化的致病和衰老相关机制。一种整体模型。
Am J Respir Crit Care Med. 2014 May 15;189(10):1161-72. doi: 10.1164/rccm.201312-2221PP.
6
C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.C-X-C基序趋化因子13(CXCL13)是特发性肺纤维化的一种预后生物标志物。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC.
7
Fibrotic extracellular matrix activates a profibrotic positive feedback loop.纤维化细胞外基质激活了一个促纤维化的正反馈回路。
J Clin Invest. 2014 Apr;124(4):1622-35. doi: 10.1172/JCI71386. Epub 2014 Mar 3.
8
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.特发性肺纤维化患者外周血单个核细胞基因表达谱预测不良预后。
Sci Transl Med. 2013 Oct 2;5(205):205ra136. doi: 10.1126/scitranslmed.3005964.
9
Common pathways in idiopathic pulmonary fibrosis and cancer.特发性肺纤维化和癌症的共同途径。
Eur Respir Rev. 2013 Sep 1;22(129):265-72. doi: 10.1183/09059180.00003613.
10
Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis.肺周细胞和固有成纤维细胞在肺纤维化发病机制中的作用。
Am J Respir Crit Care Med. 2013 Oct 1;188(7):820-30. doi: 10.1164/rccm.201212-2297OC.